Regen BioPharma Inc (RGBP)

[cvinvestor]

Stepping aside from the minute by minute broadcast of a penny stock's performance, something struck me this morning. With the hire of Ichim's as employees and Koos hiring himself as CEO, it escaped me at the time, but didn't Koos take a pay cut in the process? His new salary is $180,000/yr.

Seems to me that somewhere before he was paying himself $300,000-$400,000 on paper or is that still the case under BMSN? Can anyone else comment on this?

My thought is this: if in fact Koos cut a pay cut and stabilized his salary, about the only reason I can think of is that he was pressured into doing it by someone outside in return for a future agreement, i.e., company B agrees in principle to work with RGBP only if the IP and the scientists (Ichims) are directly under RGBP with agreed upon costs.

As others have said, we believe in the science while having doubts about Koos. An outside partner may see it the same way. All hires were for 3 years and company B might have proposed: We will invest/partner with RGBP under these conditions: the scientists work on project X full time as employees, Koos takes a salary cut and we invest X resources with a 3 year timeline of bringing x,y,z to a point of human trials for a % cut of x,y,z. If it does not make it to trials within such and such a time frame, the deal is off....

Others comments.

AIMO